Connection

Alicia Jenkins to Placebos

Back to Details
This is a "connection" page, showing publications Alicia Jenkins has written about Placebos.
Alicia Jenkins
Connection Strength
0.086
Placebos
  1. FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease. Sci Rep. 2020 12 10; 10(1):21655.
    View in: PubMed
    Score: 0.045
  2. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2012 Dec; 97(12):4701-8.
    View in: PubMed
    Score: 0.026
  3. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke. 2005 Oct; 36(10):2143-7.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.